TRANSFLUOR® provides a universal cell-based assay for screening g-protein-coupled receptors

Handbook of Assay Development in Drug Discovery

Volumn , Issue , 2006, Pages 431-453

  Oakley, Robert H ^a   Cowan, Conrad L ^b   Hudson, Christine C ^a   Loomis, Carson R ^c  

^a Xsira Pharmaceuticals   (United States)

^b Carad Therapeutics   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85130297170     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. Bockaert J, Pin JP. Molecular tinkering of G-protein-coupled receptors: an evolutionary success. EMBO J 1999; 18:1723-1729.
2. Bailey WJ, Vanti WB, George SR, Blevins R, Swaminathan S, Bonini JA, Smith KE, Weinshank RL, O'Dowd BF. Patent status of the therapeutically important G-protein-coupled receptors. Expert Opin Ther Patents 2001; 11:1861-1887.
3. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995; 80:249-257.
4. Hall RA, Premont RT, Lefkowitz RJ. Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol 1999; 145:927-932.
5. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal:desensitization of ß-adrenergic function. FASEB J 1990; 4:2881-2889.
6. Perry SJ, Lefkowitz RJ. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol 2002; 12:130-138.
7. Ferguson SS. Evolving concepts in G-protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 2001; 53:1-24.
8. Benovic JL, Mayor F Jr, Staniszewski C, Lefkowitz RJ, Caron MG. Purification and characterization of the beta-adrenergic receptor kinase. J Biol Chem 1987; 262:9026-9032.
9. Chen CK, Burns ME, Spencer M, Niemi GA, Chen J, Hurley JB, Baylor DA, Simon MI. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci USA 1999; 96:3718-3722.
10. Pitcher JA, Freedman NJ, Lefkowitz RJ. G-protein-coupled receptor kinases. Annu Rev Biochem 1998; 67:653-692.
11. Ferguson SS, Downey WE, Colapietro AM, Barak LS, Menard L, Caron MG. Role of beta-arrestin in mediating agonist-promoted G-protein-coupled receptor internalization. Science 1996; 271:363-366.
12. Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 1996; 383:447-450.
13. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits. J Biol Chem 2000; 275:23,120-23,126.
14. Palczewski K, McDowell JH, Jakes S, Ingebritsen TS, Hargrave PA. Regulation of rhodopsin dephos-phorylation by arrestin. J Biol Chem 1989; 264:15,770-15,773.
15. Krueger KM, Daaka Y, Pitcher JA, Lefkowitz RJ. The role of sequestration in G-protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem 1997; 272:5-8.
16. Zhang J, Barak LS, Winkler KE, Caron MG, Feruson SS. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J Biol Chem 1997; 272:27,005-27,014.
17. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. Association of beta-arrestin with G-pro-tein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 1999; 274:32,248-32,257.
18. Tsao P, Cao T, von Zastrow M. Role of endocytosis in mediating downregulation of G-protein-coupled receptors. Trends Pharmacol Sci 2001; 22:91-96.
19. Bohm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signaling by G-protein-cou-pled receptors. Biochem J 1997; 322:1-18.
20. Pierce KL, Lefkowitz RJ. Classical and new roles of beta-arrestins in the regulation of G-protein-cou-pled receptors. Nat Rev Neurosci 2001; 2:727-733.
21. Luttrell LM, Lefkowitz RJ. The role of beta-arrestins in the termination and transduction of G-pro-tein-coupled receptor signals. J Cell Sci 2002; 115:455-165.
22. Spiegel AM. Defects in G protein-coupled signal transduction in human diseases. Annu Rev Physiol 1996; 58:143-170.
23. Rana BK, Shiina T, Insel PA. Genetic variations and polymorphisms of G-protein-coupled receptors: functional and therapeutic implications. Annu Rev Pharmacol Toxicol 2001; 41:593-624.
24. Howard AD. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci 2001; 22:132-140.
25. Angrist M. GPCRs: Mining the richest vein in drug discovery. Cambridge Healthtech Institute Insights Report, LLC 2003.
26. Wise A, Jupe SC, Rees S. The identification of ligands at orphan G-protein-coupled receptors. Annu Rev Pharmacol Toxicol 2004; 44:43-66.
27. Barak LS, Ferguson SS, Zhang J, Caron MG. A beta-arrestin/green fluorescent protein biosensor for detecting G-protein-coupled receptor activation. J Biol Chem 1997; 272:27,497-27,500.
28. Oakley RH, Hudson CC, Cruickshank RD, Meyers DM, Payne RE, Rhem SM, Loomis CR. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G-protein-coupled receptors. Assay Drug Dev Technol 2002; 1:21-30.
29. Johnson EC, Bohn LM, Barak LS, Birse RT, Nassel DR, Caron MG, Taghert PH. Identification of Drosophila neuropeptide receptors by G-protein-coupled receptors/beta-arrestin2 interactions. J Biol Chem 2003; 278:52,172-52,178.
30. Mundell SJ, Benovic JL. Selective regulation of endogenous G-protein-coupled receptors by arrestins in HEK293 cells. J Biol Chem 2000; 275:12,900-12,908.
31. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, Caron MG, Barak LS. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 1999; 96:3712-3717.
32. Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG, Ferguson SS. Cellular trafficking of G-protein-coupled receptor/beta-arrestin endocytic complexes. J Biol Chem 1999; 274:10,999-11,006.
33. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000; 275:17,201-17,210.
34. Oakley RH, Barak LS, Caron MG. Real time imaging of GPCR-mediated arrestin translocation as a strategy to evaluate receptor-protein interactions. In: George SR, O'Dowd BF, eds. G Protein-Coupled Receptor-Protein Interactions. John Wiley & Sons, New York, 2005, 53-80.
35. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. Molecular determinants underlying the formation of stable intracellular G-protein-coupled receptor/beta-arrestin complexes after receptor endocytosis. J Biol Chem 2001; 276:19,452-19,460.
36. Liggett SB, Freedman NJ, Schwinn DA, Lefkowitz RJ. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci USA 1993; 90:3665-3669.
37. Cao W, Luttrell LM, Medvedev AV, Pierce KL, Daniel KW, Dixon TM, Lefkowitz RJ, Collins S. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 2000; 275:38,131-38,134.
38. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J Jr, Lefkowitz RJ, Caron MG, Giros B. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci USA 1996; 93:12,974-12,979.
39. Peppel K, Boekhoff I, McDonald P, Breer H, Caron MG, Lefkowitz RJ. G-protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J Biol Chem 1997; 272:25,425-25,428.
40. Gainetdinov RR, Bohn LM, Walker JK, Laporte SA, Macrae AD, Caron MG, Lefkowitz RJ, Premont RT. Muscarinic supersensitivity and impaired receptor desensitization in G-protein-coupled receptor kinase 5-deficient mice. Neuron 1999; 24:1029-1036.
41. Dale LB, Bhattacharya M, Seachrist JL, Anborgh PH, Ferguson SS. Agonist-stimulated and tonic internalization of metabotropic glutamate receptor 1a in human embryonic kidney 293 cells: agonist-stimulated endocytosis is beta-arrestin1 isoform-specific. Mol Pharmacol 2001; 60:1243-1253.
42. Marion S, Weiner DM, Caron MG. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 2004; 279:2945-2954.
43. Miller WE, Houtz DA, Nelson CD, Kolattukudy PE, Lefkowitz RJ. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. J Biol Chem 2003; 278:21,663-21,671.
44. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999; 4:67-73.
45. Burgueno J, Blake DJ, Benson MA, Tinsley CL, Esapa CT, Canela EI, Penela P, Mallol J, Mayor F Jr, Lluis C, Franco R, Ciruela F. The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. J Biol Chem 2003; 278:37,545-37,552.
46. Mundell SJ, Matharu AL, Kelly E, Benovic JL. Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry 2000; 39:12,828-12,836.
47. Matharu AL, Mundell SJ, Benovic JL, Kelly E. Rapid agonist-induced desensitization and internal-ization of the A(2B) adenosine receptor is mediated by a serine residue close to the COOH terminus. J Biol Chem 2001; 276:30,199-30,207.
48. Penn RB, Pascual RM, Kim YM, Mundell SJ, Krymskaya VP, Panettieri RA Jr, Benovic JL. Arrestin specificity for G-protein-coupled receptors in human airway smooth muscle. J Biol Chem 2001; 276:32,648-32,656.
49. Shiina T, Kawasaki A, Nagao T, Kurose H. Interaction with beta-arrestin determines the difference in internalization behavior between beta1- and beta2-adrenergic receptors. J Biol Chem 2000; 275:29,082-29,090.
50. Barak LS, Oakley RH, Shetzline MA. G-protein-coupled receptor desensitization as a measure of signaling: modeling of arrestin recruitment to activated CCK-B receptors. Assay Drug Dev Technol 2003; 1:409-424.
51. Kishi H, Krishnamurthy H, Galet C, Bhaskaran RS, Ascoli M. Identification of a short linear sequence present in the C-terminal tail of the rat follitropin receptor that modulates arrestin-3 binding in a phosphorylation-independent fashion. J Biol Chem 2002; 277:21,939-21,946.
52. Min L, Galet C, Ascoli M. The association of arrestin-3 with the human lutropin/choriogonadotropin receptor depends mostly on receptor activation rather than on receptor phosphorylation. J Biol Chem 2002; 277:702-710.
53. Ferrari SL, Behar V, Chorev M, Rosenblatt M, Bisello A. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem 1999; 274:29,968-29,975.
54. Vilardaga JP, Frank M, Krasel C, Dees C, Nissenson RA, Lohse MJ. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G-protein-coupled receptor kinase in the G-protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein. J Biol Chem 2001; 276:33,435-33,443.
55. Vilardaga JP, Krasel C, Chauvin S, Bambino T, Lohse MJ, Nissenson RA. Internalization determinants of the parathyroid hormone receptor differentially regulate beta-arrestin/receptor association. J Biol Chem 2002; 277:8121-8129.
56. Desai S, Ashby B. Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor. FEBS Lett 2002; 501:156-160.
57. Walker JK, Premont RT, Barak LS, Caron MG, Shetzline MA. Properties of secretin receptor inter-nalization differ from those of the beta(2)-adrenergic receptor. J Biol Chem 1999; 274:31,515-31,523.
58. Shetzline MA, Walker JK, Valenzano KJ, Premont RT. Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestration. J Biol Chem 2002; 277:25,519-25,526.
59. Ferguson SS, Zhang J, Barak LS, Caron MG. Molecular mechanisms of G-protein-coupled receptor desensitization and resensitization. Life Sci 1998; 62:1561-1565.
60. Ferguson G, Watterson KR, Palmer TM. Subtype-specific regulation of receptor internalization and recycling by the carboxyl-terminal domains of the human A1 and rat A3 adenosine receptors: consequences for agonist-stimulated translocation of arrestin3. Biochemistry 2002; 41:14,748-14,761.
61. Evans NA, Groarke DA, Warrack J, Greenwood CJ, Dodgson K, Milligan G, Wilson S. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G-protein-coupled receptors. J Neurochem 2001; 77:476-485.
62. Lee DK, Lanca AJ, Cheng R, Nguyen T, Ji XD, Gobeil F Jr, Chemtob S, George SR, O'Dowd BF. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 2004; 279:7901-7908.
63. Braun L, Christophe T, Boulay F. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-depen-dent pathway. J Biol Chem 2003; 278:4277-4285.
64. Richardson RM, Marjoram RJ, Barak LS, Snyderman R. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J Immunol 2003; 170:2904-2911.
65. Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, Caron MG. Differential regulation of the dopamine D2 and D3 receptors by G-protein-coupled receptor kinases and beta-arrestins. J Biol Chem 2001; 276:37,409-37,414.
66. Hobson JP, Rosenfeldt HM, Barak LS, Olivera A, Poulton S, Caron MG, Milstien S, Spiegel S. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 2001; 291:1800-1803.
67. Key TA, Foutz TD, Gurevich VV, Sklar LA, Prossnitz ER. N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity. J Biol Chem 2003; 278:4041-4047.
68. Galliera E, Jala VR, Trent JO, Bonecchi R, Signorelli P, Lefkowitz RJ, Mantovani A, Locati M, Haribabu B. beta-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 2004; 279:25,590-25,597.
69. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Milligan G, Groarke DA, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G-protein-coupled receptor. J Biol Chem 2000; 275:25,965-25,971.
70. Zhang J, Ferguson SS, Law PY, Barak LS, Caron MG. Agonist-specific regulation of delta-opioid receptor trafficking by G-protein-coupled receptor kinase and beta-arrestin. J Recept Signal Transduct Res 1999; 19:301-313.
71. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, Caron MG. Role for G-protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 1998; 95:7157-7162.
72. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V, Schulz S. Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 2004; 279:21,374-21,382.
73. Heding A, Vrecl M, Hanyaloglu AC, Sellar R, Taylor PL, Eidne KA. The rat gonadotropin-releasing hormone receptor internalizes via a beta-arrestin-independent, but dynamin-dependent, pathway: addition of a carboxyl-terminal tail confers beta-arrestin dependency. Endocrinology 2000; 141:299-306.
74. McArdle CA, Franklin J, Green L, Hislop JN. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors. J Endocrinol 2002; 173:1-11.
75. Bhatnagar A, Willins DL, Gray JA, Woods J, Benovic JL, Roth BL. The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. J Biol Chem 2001; 276:8269-8277.
76. Mundell SJ, Matharu AL, Pula G, Holman D, Roberts PJ, Kelly E. Metabotropic glutamate receptor 1 internalization induced by muscarinic acetylcholine receptor activation: differential dependency of internalization of splice variants on nonvisual arrestins. Mol Pharmacol 2002; 61:1114-1123.
77. McConalogue K, Dery O, Lovett M, Wong H, Walsh JH, Grady EF, Bunnett NW. Substance P-induced trafficking of beta-arrestins. The role of beta-arrestins in endocytosis of the neurokinin-1 receptor. J Biol Chem 1999; 274:16,257-16,268.
78. Barak LS, Warabi K, Feng X, Caron MG, Kwatra MM. Real-time visualization of the cellular redistribution of G-protein-coupled receptor kinase 2 and beta-arrestin 2 during homologous desen-sitization of the substance P receptor. J Biol Chem 1999; 274:7565-7569.
79. Schmidlin F, Dery O, Bunnett NW, Grady EF. Heterologous regulation of trafficking and signaling of G-protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptors. Proc Natl Acad Sci USA 2002; 99:3324-3329.
80. Dery O, Thoma MS, Wong H, Grady EF, Bunnett NW. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor. J Biol Chem 1999; 274:18,524-18,535.
81. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. beta-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000; 148:1267-1281.
82. Chen Z, Dupre DJ, Le Gouill C, Rola-Pleszczynski M, Stankova J. Agonist-induced internalization of the platelet-activating factor receptor is dependent on arrestins but independent of G-protein activation. Role of the C terminus and the (D/N)PXXY motif. J Biol Chem 2002; 277:7356-7362.
83. Groarke DA, Drmota T, Bahia DS, Evans NA, Wilson S, Milligan G. Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein. Mol Pharmacol 2001; 59:375-385.
84. Hanyaloglu AC, Seeber RM, Kohout TA, Lefkowitz RJ, Eidne KA. Homo- and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2. J Biol Chem 2002; 277:50,422-50,430.
85. Terrillon S, Barberis C, Bouvier M. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci USA 2004; 101:1548-1553.
86. Chen W, ten Berge D, Brown J, Ahn S, Hu LA, Miller WE, Caron MG, Barak LS, Nusse R, Lefkowitz RJ. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 2003; 301:1391-1394.